Differential selectivity of CIITA promoter activation by IFN-γ and IRF- 1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α

Journal of Neuroimmunology

Volumn 99, Issue 2, 1999, Pages 195-204

  Nikcevich, Kelly M ^a   Piskurich, Janet F ^a   Hellendall, Ronald P ^a   Wang, Ying ^a   Ting, Jenny P Y ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Brain; EAE MS; MHC; Neuroimmunology; Transcription factors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; ASTROCYTE; AUTOIMMUNE DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEMYELINATING DISEASE; GENETIC TRANSCRIPTION; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN; CELLS, CULTURED; DNA-BINDING PROTEINS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; GENES, REPORTER; INTERFERON REGULATORY FACTOR-1; INTERFERON TYPE II; LUCIFERASES; MACROPHAGES; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PREGNANCY; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032703084     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00117-4     Document Type: Article

References (55)

1. Benveniste E.N., Sparacio S.M., Bethea J.R. Tumor necrosis factor-α enhances interferon-γ-mediated class II antigen expression on astrocytes. J. Neuroimmunol. 25:1989;209-219.
2. Benveniste E.N., Kwon J., Chung W.J., Sampson J., Pandya K., Tang L.P. Differential modulation of astrocyte cytokine gene expression by TGF-β J. Immunol. 153:1994;5210-5221.
3. Birnbaum G., Kotilinek L. Immunologic differences in murine glial cells and their association with susceptibility to experimental allergic encephalomyelitis. J. Neuroimmunol. 26:1990;119-129.
4. Borrow P., Nash A.A. Susceptibility to Theiler's virus-induced demyelinating disease correlates with astrocyte class II induction and antigen presentation. Immunology. 76:1992;133-139.
5. Brasier A.R., Tate J.E., Habener J.F. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. Biotechnology. 7:1989;1116-1122.
6. Chang C.H., Flavell R.A. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:1995;765-767.
7. Devajyothi C., Kalvakolanu I., Babcock G.T., Vasavada H.A., Howe P.H., Ransohoff R.M. Inhibition of interferon-gamma-induced major histocompatibility complex class II gene transcription by interferon-beta and type beta 1 transforming growth factor in human astrocytoma cells. Definition of cis-element. J. Biol. Chem. 268:1993;18794-18800.
8. de Waal Malefyt R., Haanen J., Spits H., Roncarolo M.G., te Velde A., Figdor C., Johnson K., Kastelein R., Yssel H., de Vries J.E. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:1991;915-924.
9. Dong Y., Rohn W.M., Benveniste E.N. IFN-γ regulation of the type IV class II transactivator promoter in astrocytes. J. Immunol. 162:1999;4731-4739.
10. Fierz W., Endler B., Reske K., Wekerle H., Fontana A. Astrocytes as antigen-presenting cells: I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134:1985;3785-3793.
11. Fontana A., McAdam K.P., Kristensen F., Weber E. Biological and biochemical characterization of an interleukin 1-like factor from rat C6 glioma cells. Eur. J. Immunol. 13:1983;685-689.
12. Fontes J.D., Jabrane-Ferrat N., Joth C.R., Peterlin B.M. Binding and cooperative interactions between two B cell-specific transcriptional coactivators. J. Exp. Med. 183:1996;2517-2521.
13. Fontana A., Erb P., Pircher H., Zinkernagel R., Weber E., Fierz W. Astrocytes as antigen-presenting cells: Part II. Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J. Neuroimmunol. 12:1986;15-28.
14. Frei K., Bodmer S., Schwerdel C., Fontana A. Astrocytes of the brain synthesize interleukin 3-like factors. J. Immunol. 135:1985;4044-4047.
15. Frei K., Malipiero U.V., Leist T.P., Zinkernagel R.M., Schwab M.E., Fontana A. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:1989;689-694.
16. Frei K., Lins H., Schwerdel C., Fontana A. Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J. Immunol. 152:1994;2720-2728.
17. Friedmann A., Frankel G., Lorch Y., Steinman L. Monoclonal anti-I-A antibody reverses chronic paralysis and demyelination in Theiler's virus-infected mice: critical importance of timing of treatment. J. Virol. 61:1987;898-903.
18. Glimcher L.H., Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:1992;13-49.
19. Hailer N.P., Heppner F.L., Haas D., Nitsch R. Astrocytic factors deactivate antigen presenting cells that invade the central nervous system. Brain Pathol. 8:1998;459-474.
20. Hartung H.P., Heininger K., Toyka K.V. Primary rat astroglial cultures can generate leukotriene B4. J. Neuroimmunol. 19:1988;237-243.
21. Hellendall R.P., Ting J.P. Differential regulation of cytokine-induced major histocompatibility complex class II expression and nitric oxide release in rat microglia and astrocytes by effectors of tyrosine kinase, protein kinase C, and cAMP. J. Neuroimmunol. 74:1997;19-29.
22. Jonker M., van Lambalgen R., Mitchell D.J., Durham S.K., Steinman L. Successful treatment of EAE in rhesus monkeys with MHC class II specific monoclonal antibodies. J. Autoimmun. 1:1988;399-414.
23. Kretsovali A., Agalioti T., Spilianakis C., Tzortzakaki E., Merika M., Papamatheakis J. Involvement of CREB binding protein in expression of major histocompatibility complex class II genes via interaction with the class II transactivator. Mol. Cell. Biol. 18:1998;6777-6783.
24. Lee Y.-J., Han Y., Lu H.-T., Nguyen V., Qin H., Howe P.H., Hocevar B.A., Boss J.M., Ransohoff R.M., Benveniste E.N. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J. Immunol. 158:1997;2065-2075.
25. Lennon A.M., Ottone C., Rigaud G., Deaven L.L., Longmire J., Fellous M., Bono R., Alcaide-Loridan C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics. 45:1997;266-273.
26. Male D., Pryce G. Induction of Ia molecules on brain endothelium is related to susceptibility to experimental allergic encephalomyelitis. J. Neuroimmunol. 21:1989;87-90.
27. Massa P.T., Brinkmann R., ter Meulen V. Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain dependent. J. Exp. Med. 166:1987;259-264.
28. Massa P.T., ter Meulen V., Fontana A. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4219-4223.
29. Matsushima G.K., Taniike M., Glimcher L.H., Grusby M.J., Frelinger J.A., Suzuki K., Ting J.P. Absence of MHC class II molecules reduces CNS demyelination, microglial/macrophage infiltration, and twitching in murine globoid cell leukodystrophy. Cell. 78:1994;645-656.
30. McCarthy K.D., De Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Cell Biol. 85:1980;890-902.
31. Morga E., Heuschling P. Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes. Glia. 17:1996;175-179.
32. Moses H., Sasaki A., Ting J.P. Identification of an interferon-gamma-responsive element of a class II major histocompatibility gene in rat type 1 astrocytes. J. Neuroimmunol. 31:1991;273-278.
33. Muhlethaler-Mottet A., Otten L.A., Steimle V., Mach B. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16:1997;2851-2860.
34. Muhlethaler-Mottet A., Di Berardino W., Otten L.A., Mach B. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1. Immunity. 8:1998;157-166.
35. Peress N.S., Perillo E., Seidman R.J. Glial transforming growth factor (TGF)-beta isotypes in multiple sclerosis: differential glial expression of TGF-beta 1, 2 and 3 isotypes in multiple sclerosis. J. Neuroimmunol. 71:1996;115-123.
36. Piskurich J.F., Wang Y., Linhoff M.W., White L.C., Ting J.P.-Y. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160:1998;233-240.
37. Piskurich J.F., Linhoff M.W., Wang Y., Ting J.P.-Y. Two distinct gamma interferon-inducible promoters of the major histocompatibility complex class II transactivator gene are differentially regulated by STAT1, interferon regulatory factor I, and transforming growth factor β Mol. Cell. Biol. 19:1999;431-440.
38. Raschke W.C., Baird S., Ralph P., Nanoinz I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell. 15:1978;261-267.
39. Rein T., Muller M., Zorbas H. In vivo footprinting of the IRF-1 promoter: inducible occupation of a GAS element next to a persistent structural alteration of the DNA. Nucleic Acids Res. 22:1994;3033-3037.
40. Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M. Activation of class II MHC genes requires both the X box region and the class II transactivator (CIITA). Immunity. 2:1995;533-543.
41. Robbins D.S., Shirazi Y., Drysdale B.E., Lieberman A., Shin H.S., Shin M.L. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:1987;2593-2597.
42. Sasaki A., Levison S.W., Ting J.P. Comparison and quantitation of Ia antigen expression on cultured macroglia and ameboid microglia from Lewis rat cerebral cortex: analyses and implications. J. Neuroimmunol. 25:1989;63-74.
43. Sasaki A., Levison S.W., Ting J.P. Differential suppression of interferon-gamma-induced Ia antigen expression on cultured rat astroglia and microglia by second messengers. J. Neuroimmunol. 29:1990;213-222.
44. Sawada M., Kondo N., Suzumura A., Marunouchi T. Production of tumor necrosis factor-alpha by microglia and astrocytes in culture. Brain Res. 491:1989;394-397.
45. Scholl T., Mahanta S.K., Strominger J.L. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6330-6334.
46. Smith R.M., Morgan A., Wraith D.C. Anti-class II MHC antibodies prevent and treat EAE without APC depletion. Immunology. 83:1994;1-8.
47. Soos J.M., Morrow J., Ashley T.A., Szente B.E., Bikoff E.K., Zamvil S.S. Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells. J. Immunol. 161:1998;5959-5966.
48. Sriram S., Steinman L. Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes. J. Exp. Med. 158:1983;1362-1367.
49. Sriram S., Topham D.J., Carroll L. Haplotype-specific suppression of experimental allergic encephalomyelitis with anti-IA antibodies. J. Immunol. 139:1987;1485-1489.
50. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 265:1994;106-109.
51. Steinman L. The use of monoclonal antibodies for treatment of autoimmune disease. J. Clin. Immunol. 10:1990;30-38.
52. Tedeschi B., Barrett J.N., Keane R.W. Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J. Cell Biol. 102:1986;2244-2253.
53. Vivien D., Bernaudin M., Buisson A., Divoux D., MacKenzie E.T., Nouvelot A. Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia. J. Neurochem. 70:1998;2296-2304.
54. Welsh J., Sapatino B., Rosenbaum B., Smith R., Linthicum S. Correlation between susceptibility to demyelination and interferon-gamma induction of major histocompatibility complex class II antigens on murine cerebrovascular endothelial cells. J. Neuroimmunol. 48:1993;91-97.
55. Wong G.H., Bartlett P.F., Clark-Lewis I., Battye F., Schrader J.W. Inducible expression of H-2 and Ia antigens on brain cells. Nature. 310:1984;688-691.